OCEL Stock Price, News & Analysis

OCEL OTC

Company Description

OCEL (OTC: OCEL) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.

OCEL stock has declined 52.1% over the past year.

This page provides a comprehensive overview of OCEL stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-52.08%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

OCEL (OCEL) stock. Over the past 12 months, the stock has lost 52.1%.

Latest News

View All

November 27, 2023

-11.46%

Organicell Announces 1-for-200 Reverse Stock Split

stock split

July 26, 2023

+2.63%

Organicell Reports Interim Results of Phase 1/2A Research Program

clinical trial

June 29, 2023

+1.01%

Organicell Welcomes Howard Golub, MD, PhD As Its New EVP/CSO

June 21, 2023

+5.26%

Organicell Welcomes Harry Leider, MD, MBA as its New CEO

management

November 17, 2022

+22.78%

Organicell Starts Enrolling Long COVID Trial

covid-19

November 15, 2022

+35.34%

Organicell Activates COPD Trial at Mayo Clinic

OCEL has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include stock split, clinical trial, management, covid-19, partnership. View all OCEL news →

SEC Filings

View All

No SEC filings available for OCEL.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

OCEL Company Profile & Sector Positioning

OCEL (OCEL) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the OTC.